• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素-γ 在泡沫细胞形成和动脉粥样硬化进展中的作用。

Interferon-γ in foam cell formation and progression of atherosclerosis.

机构信息

Life Science Research Center, Key Laboratory for Atherosclerology of Hunan Province, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan 421001, China.

Department of Spine, The First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, China.

出版信息

Clin Chim Acta. 2015 Feb 20;441:33-43. doi: 10.1016/j.cca.2014.12.007. Epub 2014 Dec 13.

DOI:10.1016/j.cca.2014.12.007
PMID:25512166
Abstract

Interferon-γ (IFN-γ), the sole member in type II IFN predominantly secreted by macrophages and T cells, is a critical regulator of immune function and provides a robust first line of defense against invading pathogens. Binding of IFN-γ to its receptor complex can activate a variety of downstream signaling pathways, particularly the Janus kinase (JAK)/signal transducer and activator of transcription (STAT), to induce gene transcription within the target cells. This pro-inflammatory mediator is highly expressed in atherosclerotic lesions and promotes foam cell formation, but its effects on the atherogenesis are complex, with both pro- and anti-atherogenic properties. IFN-γ also contributes to the development of myocardial infarction and stroke, the two main atherosclerotic diseases. Inhibition of IFN-γ signaling may prevent the development of atherosclerosis and help treat atherosclerotic diseases. Since IFN-γ may also exert anti-atherogenic effects, the safety and efficacy of anti-IFN-γ treatment still require careful evaluation in the clinical setting. In the current review, we summarize recent progression on regulation and signaling pathways of IFN-γ, and highlight its roles in foam cell formation, atherosclerosis, myocardial infarction as well as stroke. An increased understanding of these processes will help to develop novel IFN-γ-centered therapies for atherosclerotic diseases.

摘要

干扰素-γ(IFN-γ)是唯一一种主要由巨噬细胞和 T 细胞分泌的 II 型 IFN,是免疫功能的关键调节剂,为抵御入侵病原体提供了强大的第一道防线。IFN-γ 与受体复合物的结合可以激活多种下游信号通路,特别是 Janus 激酶(JAK)/信号转导和转录激活因子(STAT),从而在靶细胞内诱导基因转录。这种促炎介质在动脉粥样硬化病变中高度表达,并促进泡沫细胞形成,但它对动脉粥样形成的影响是复杂的,具有促动脉粥样和抗动脉粥样形成的特性。IFN-γ 也有助于心肌梗死和中风这两种主要的动脉粥样硬化疾病的发展。抑制 IFN-γ 信号可能会阻止动脉粥样硬化的发展,并有助于治疗动脉粥样硬化疾病。由于 IFN-γ 也可能发挥抗动脉粥样作用,因此在临床环境中仍需要仔细评估抗 IFN-γ 治疗的安全性和疗效。在当前的综述中,我们总结了 IFN-γ 调节和信号通路的最新进展,并强调了它在泡沫细胞形成、动脉粥样硬化、心肌梗死和中风中的作用。对这些过程的深入了解将有助于开发以 IFN-γ 为中心的动脉粥样硬化疾病的新疗法。

相似文献

1
Interferon-γ in foam cell formation and progression of atherosclerosis.干扰素-γ 在泡沫细胞形成和动脉粥样硬化进展中的作用。
Clin Chim Acta. 2015 Feb 20;441:33-43. doi: 10.1016/j.cca.2014.12.007. Epub 2014 Dec 13.
2
Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages.干扰素-γ阻碍胆固醇逆向转运并促进THP-1人单核细胞/巨噬细胞向泡沫细胞转变。
Med Sci Monit. 2004 Nov;10(11):BR420-5. Epub 2004 Oct 26.
3
STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.STAT1 作为一个新型治疗靶点,在 IFNγ、TLR4 和 IL-6 介导的动脉粥样硬化发病信号通路中起关键作用。
Cytokine Growth Factor Rev. 2011 Aug;22(4):211-9. doi: 10.1016/j.cytogfr.2011.06.003. Epub 2011 Jul 12.
4
Interferon gamma: a master regulator of atherosclerosis.γ干扰素:动脉粥样硬化的主要调节因子。
Cytokine Growth Factor Rev. 2009 Apr;20(2):125-35. doi: 10.1016/j.cytogfr.2008.11.003. Epub 2008 Nov 28.
5
Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.细胞因子、巨噬细胞脂质代谢与泡沫细胞:对心血管疾病治疗的启示。
Prog Lipid Res. 2011 Oct;50(4):331-47. doi: 10.1016/j.plipres.2011.04.002. Epub 2011 May 13.
6
Interferon-gamma and atherosclerosis: pro- or anti-atherogenic?γ干扰素与动脉粥样硬化:促动脉粥样硬化还是抗动脉粥样硬化?
Cardiovasc Res. 2005 Jul 1;67(1):11-20. doi: 10.1016/j.cardiores.2005.04.019.
7
Gamma interferon: a central mediator in atherosclerosis.γ干扰素:动脉粥样硬化的关键介质
Inflamm Res. 2005 Oct;54(10):395-411. doi: 10.1007/s00011-005-1377-2.
8
Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-gamma-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis.酪蛋白激酶2和磷酸肌醇-3-激酶在干扰素-γ诱导的单核细胞趋化蛋白-1及其他与动脉粥样硬化相关关键基因表达中的关键作用。
Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):806-12. doi: 10.1161/01.ATV.0000258867.79411.96. Epub 2007 Jan 25.
9
The role of interferon-γ in cardiovascular disease: an update.γ 干扰素在心血管疾病中的作用:最新研究进展。
Inflamm Res. 2020 Oct;69(10):975-988. doi: 10.1007/s00011-020-01382-6. Epub 2020 Jul 22.
10
Atherosclerosis and interferon-γ: new insights and therapeutic targets.动脉粥样硬化与干扰素-γ:新的认识与治疗靶点。
Trends Cardiovasc Med. 2014 Jan;24(1):45-51. doi: 10.1016/j.tcm.2013.06.003. Epub 2013 Aug 2.

引用本文的文献

1
Interferon Gamma and Tumor Necrosis Factor Alpha Are Inflammatory Biomarkers for Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease.干扰素γ和肿瘤坏死因子α是外周动脉疾病患者主要不良心血管事件的炎症生物标志物。
Biomedicines. 2025 Jun 29;13(7):1586. doi: 10.3390/biomedicines13071586.
2
Chronic Inflammatory Diseases and Cardiovascular Risk: Current Insights and Future Strategies for Optimal Management.慢性炎症性疾病与心血管风险:当前见解及优化管理的未来策略
Int J Mol Sci. 2025 Mar 27;26(7):3071. doi: 10.3390/ijms26073071.
3
Innovations in Vascular Repair from Mechanical Intervention to Regenerative Therapies.
血管修复的创新:从机械干预到再生疗法
Tissue Eng Regen Med. 2025 Feb 8. doi: 10.1007/s13770-024-00700-x.
4
Immunological perspectives on atherosclerotic plaque formation and progression.免疫视角下的动脉粥样硬化斑块形成与进展。
Front Immunol. 2024 Sep 27;15:1437821. doi: 10.3389/fimmu.2024.1437821. eCollection 2024.
5
A dietary intervention with conjugated linoleic acid enhances microstructural white matter reorganization in experimental stroke.共轭亚油酸饮食干预可增强实验性中风中微观结构白质的重组。
Front Neurol. 2024 Sep 20;15:1341958. doi: 10.3389/fneur.2024.1341958. eCollection 2024.
6
Exploring causal correlations between inflammatory cytokines and intervertebral disc degeneration: A Mendelian randomization.探索炎性细胞因子与椎间盘退变之间的因果关系:孟德尔随机化研究
JOR Spine. 2024 Jul 10;7(3):e1349. doi: 10.1002/jsp2.1349. eCollection 2024 Sep.
7
Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis.调节动脉内膜中泡沫细胞形成的机制:探索动脉粥样硬化的新治疗机会。
Front Cardiovasc Med. 2024 Jun 17;11:1381520. doi: 10.3389/fcvm.2024.1381520. eCollection 2024.
8
Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis.靶向肠道微生物群与免疫串扰:天然产物治疗动脉粥样硬化的潜在机制
Front Pharmacol. 2023 Sep 1;14:1252907. doi: 10.3389/fphar.2023.1252907. eCollection 2023.
9
Single-cell atlas reveals different immune environments between stable and vulnerable atherosclerotic plaques.单细胞图谱揭示稳定和易损粥样硬化斑块之间不同的免疫环境。
Front Immunol. 2023 Jan 18;13:1085468. doi: 10.3389/fimmu.2022.1085468. eCollection 2022.
10
Deep learning predicts resistance to neoadjuvant chemotherapy for locally advanced gastric cancer: a multicenter study.深度学习预测局部进展期胃癌新辅助化疗耐药:多中心研究。
Gastric Cancer. 2022 Nov;25(6):1050-1059. doi: 10.1007/s10120-022-01328-3. Epub 2022 Aug 6.